Salinosporamides and methods for use thereof
View Patent ↗The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC 50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.
1. An isolated compound having the structure (I):
or a pharmaceutically acceptable salt thereof,
wherein:
R 1 is —H, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, alkoxy, substituted alkoxy, thioalkyl, substituted thioalkyl, hydroxy, halogen, amino, amido, carboxyl, —C(O)H, acyl, oxyacyl, carbamate, sulfonamide or sulfuryl;
wherein when R 1 is a substituted alkyl, the alkyl group can further bear one or more substituents selected from alkoxy, mercapto, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, substituted aryloxy, cyano, nitro, amino, amido, —C(O)H, acyl, oxyacyl, carboxyl, sulfonamide, and sulfuryl;
R 2 is —H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, alkoxy, substituted alkoxy, thioalkyl, substituted thioalkyl, hydroxy, halogen, amino, amido, carboxyl, —C(O)H, acyl, oxyacyl, carbamate, sulfonamide or sulfuryl;
R 3 is —H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, alkoxy, substituted alkoxy, thioalkyl, substituted thioalkyl, hydroxy, halogen, amino, amido, carboxyl, —C(O)H, acyl, oxyacyl, carbamate, sulfonamide or sulfuryl;
each R 4 is independently alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl;
E 1 to E 4 are each independently O, —NR 5 , or —S, wherein R 5 is —H or C 1-6 alkyl; and
X is 0 to 8.
2. The compound of claim 1 , wherein E 1 , E 2 , and E 4 are each —O and E 2 is —NH.
3. The compound of claim 2 , wherein R 1 is substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, cycloalkyl or substituted cycloalkyl.
4. The compound of claim 2 , wherein R 1 is substituted alkyl, alkenyl, substituted alkenyl, alkynyl or substituted alkynyl.
5. The compound of claim 2 , wherein R 1 is a substituted alkyl.
6. The compound of claim 5 , wherein R 2 is alkyl or substituted alkyl.
7. The compound of claim 5 , wherein R 3 is hydroxyl.
8. The compound of claim 2 , wherein R 2 is —H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, cycloalkyl or substituted cycloalkyl.
9. The compound of claim 2 , wherein R 2 is —H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl or substituted alkynyl.
10. The compound of claim 2 , wherein R 2 is —H, alkyl or substituted alkyl.
11. The compound of claim 2 , wherein R 2 is alkyl or substituted alkyl.
12. The compound of claim 2 , wherein R 3 is hydroxyl or alkoxy.
13. The compound of claim 2 , wherein R 3 is hydroxyl.
14. The compound of claim 1 , wherein the structure (I) is:
15. A pharmaceutically acceptable salt of a compound of claim 1 .
16. A pharmaceutical composition comprising at least one compound of claim 1 in a pharmaceutical acceptable carrier therefore.
17. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound having the structure:
wherein the pharmaceutical composition is in a form of a sterile injectable solution.
18. The pharmaceutical composition of claim 17 , wherein the sterile injectable solution is an aqueous sterile injectable solution.